AIF Downregulation and Its Interaction with STK3 in Renal Cell Carcinoma

por Xu, Shengqiang, Wu, Hongjin, Nie, Huan, Yue, Lei, Jiang, Huadong, Xiao, Sheng, Li, Yu
Publicado 2014

Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in A...

por Li, Ye, Wang, Jiaqian, Wu, Liangliang, Li, Xiaoting, Zhang, Xiaoyun, Zhang, Guoqing, Xu, Shengqiang, Sun, Shengjie, Jiao, Shunchang
Publicado 2021

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

por Liu, Jieqiong, Wang, Ying, Tian, Zhenluan, Lin, Ying, Li, Hengyu, Zhu, Zhaowen, Liu, Qiang, Su, Shicheng, Zeng, Yinduo, Jia, Weijuan, Yang, Yaping, Xu, Shengqiang, Yao, Herui, Jiang, Wen, Song, Erwei
Publicado 2022

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer

por Fang, Wenfeng, Jin, Haoxuan, Zhou, Huaqiang, Hong, Shaodong, Ma, Yuxiang, Zhang, Yaxiong, Su, Xiaofan, Chen, Longyun, Yang, Yunpeng, Xu, Shengqiang, Liao, Yuwei, He, Yuming, Zhao, Hongyun, Huang, Yan, Gao, Zhibo, Zhang, Li
Publicado 2021